Cambridge, MA — September 18, 2025 — Leads & Copy — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced it will host a virtual Research Day on Wednesday, October 29, 2025, at 10:00 a.m. ET. Members of Wave’s management team are also scheduled to participate in several upcoming investor conferences.
Erik Ingelsson, MD, PhD, Chief Scientific Officer, will participate in an analyst-led fireside chat at the Bernstein 2nd Annual Healthcare Forum on Wednesday, September 24, 2025, at 2:50 p.m. ET. Paul Bolno, MD, MBA, President and CEO, and Erik Ingelsson will participate in an analyst-led fireside chat at the Stifel Virtual Cardiometabolic Forum on Tuesday, September 30, 2025, at 1:00 p.m. ET. Bolno will also participate in a panel discussing RNA editing therapeutics at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 1:00 p.m. ET. Further details regarding Wave’s 2025 Virtual Research Day on Wednesday, October 29, 2025, at 10:00 a.m. ET will follow.
Live webcasts of these presentations can be accessed by visiting “Investor Events” on the Investors section of the Wave Life Sciences website. Replays of these presentations will be archived and available on the site for a limited time following the event.
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing. Wave is headquartered in Cambridge, MA.
Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827
Investors:
James Salierno
Director, Investor Relations
+1 617-949-4043
InvestorRelations@wavelifesci.com
Media:
Katie Sullivan
Senior Director, Corporate Communications
+1 617-949-2936
MediaRelations@wavelifesci.com
Source: Wave Life Sciences
